Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| DTS INC | DTSI | 6.89% |
| ANIKA THERAP | ANIK | 6.04% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Omnicom Group Inc. (OMC - Analyst Report) reported strong fourth quarter 2012 results with a net income of $307.1 million or $1.13 per share compared to $271.9 million or 96 cents in the year-earlier quarter. The earnings for the reported quarter exceeded the Zacks Consensus Estimate by 4 cents.
For full year 2012, the company reported a net income of $998.3 million or $3.61 per share compared to $952.6 million or $3.33 in the previous year. The earnings for 2012 surpassed the Zacks Consensus Estimate by 3 cents.
Total revenues in the reported quarter climbed 2.4% to settle at $3,944.5 million and beat the Zacks Consensus Estimate of $3,933 million. From a geographical perspective, domestic revenue accounted for 51.4% of total revenue and rose 5.1% to reach $2,026.6 million, while international revenue (representing the balance 48.6%) dipped 0.3% year over year to $1,917.9 million.
Based on disciplines, Advertising revenue grew 4.6% to $1,934.9 million in fourth quarter 2012; CRM revenue decreased 2.3% year over year to $1,368.7 million; PR revenue of $347.9 million was up 10.5% year over year; and Specialty revenue of $293.0 million was up 2.0%.
For full year 2012, total revenues were 14,219.4 million, representing a 2.5% year-over-year increase. Domestic revenue for the year increased 4.5% to $7,363.7 million, while international revenue increased 0.5% to $6,855.7 million.
On the basis of disciplines, Advertising revenue grew 4.6% to $6,762.8 million in 2012; CRM revenue rose marginally to $5,122.5 million; PR revenue surged 4.9% to $1,290.8 million; and Specialty revenue of $1,043.3 million was down 2.1% year over year.
Omnicom generated free cash flow of $1,426.1 million in 2012, up from $1,247.3 million in the preceding year. The company had a total debt of $4,455 million at year-end 2012, compared to 3,193 million in the year-ago period. Cash and short-term investments aggregated $2,699 million at year-end 2012 compared to $1,805 million in the prior year.
Omnicom has a strong track record of winning new clients and receiving additional deals from the existing ones. The company’s business mix is well diversified geographically and benefits largely from the growing markets. In addition, the company’s efforts in maintaining controlled expenses and strong global reputation are commendable.
However, the company needs to be wary of stiff competition from other players in the industry such as AirMedia Group Inc. (AMCN - Snapshot Report) and Publicis Groupe SA (PUBGY), each carrying a Zacks Rank #2 (Buy), and Harte-Hanks Inc. (HHS - Snapshot Report), carrying a Zacks Rank #1 (Strong Buy). Omnicom presently has a Zacks Rank #3 (Hold).
Get the full Analyst Report on OMC - FREE
Get the full on PUBGY - FREE
Get the full Snapshot Report on HHS - FREE
Get the full Snapshot Report on AMCN - FREE